Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$92.03

-0.39 (-0.42%)

06:47
10/06/17
10/06
06:47
10/06/17
06:47

Procter & Gamble board details perspective on proxy contest

The Procter & Gamble Board of Directors issued the following statement detailing its perspective on the P&G proxy contest. "On behalf of the Procter & Gamble Board of Directors, I want to detail why we strongly recommend voting for all of P&G's highly qualified Directors who are deeply engaged and committed to the Company and all P&G shareholders. What matters in this proxy contest is that P&G is on the right track, with the right management team, the right Board, and the right plan that is working. The Company is in the middle of a successful transformation that is producing positive results. Nearly everything about the Company is changing, and it is well positioned for future market share growth, margin growth, and leading returns to investors. Nelson Peltz of Trian is vying for a P&G Board seat in the middle of a successful transformation that is delivering results. He is a respected investor, and we are willing to listen to him, but the case for adding Mr. Peltz to the Board misses on two key factors - the timing is late, and the substance is lacking. P&G is a completely different company than it was just a few years ago. The P&G Board and management team identified the changes that were needed and have already been aggressively implementing them. Mr. Peltz's timing is late to P&G's turnaround. P&G has already executed a massive productivity program, with another major cost saving initiative underway. The brand and product portfolio has been restructured. The organization is being redesigned, moving to a by-category structure and dismantling the complex matrix. Nearly every aspect of the business is being revamped, from innovation to marketing to selling. The plan is working. Since the Board appointed David Taylor as CEO two years ago, P&G has delivered total shareholder return of 28%, outperforming peers. Sales and earnings objectives are being achieved. Margins are increasing to industry leading levels. Market shares are improving. The comprehensive actions the Board and management have taken to transform P&G and accelerate growth are delivering results. Now is the time to continue to execute and deliver, not risk going backwards. The P&G Board and management team are always open to constructive suggestions, and spend a lot of time in and out of the boardroom exploring and debating ideas. Members of the P&G Board have had numerous interactions with Mr. Peltz to listen to and understand his views, but he has only offered one substantive idea that P&G is not already doing. The one idea he is advocating - to again reorganize the Company - is a bad idea that would stall or reverse the Company's momentum. The last thing P&G needs now is a costly and time-consuming reorganization. P&G also has rigorous and substantive selection criteria for Board membership. We continually refresh the Board, looking for people with the right experience and skills needed to guide P&G into the future. We are currently looking for global experience, digital and big data/analytics experience, and skills in artificial intelligence and machine learning. We are looking for direct experience in household and personal categories, as well as in health care. And we are looking to build a Board that reflects the consumers we serve, with diversity in gender, age, and ethnicity. After extensive due diligence, we have concluded that Mr. Peltz does not fit the criteria we are seeking for the P&G Board. We respect Mr. Peltz as an investor and will continue to engage constructively with him as a P&G shareholder. The P&G Board is highly engaged, deeply committed, and is holding management accountable to deliver results for the short-, mid- and long-term. The Company is well on its way to meeting the needs of consumers and to delivering the business and financial results that you expect from P&G. Your vote is important. That is why we respectfully ask for your support for all of P&G's Directors in this proxy contest."

  • 10

    Oct

  • 20

    Oct

PG Procter & Gamble
$92.03

-0.39 (-0.42%)

08/17/17
JEFF
08/17/17
NO CHANGE
Target $103
JEFF
Buy
Procter & Gamble remains a core Staples holding, says Jefferies
Jefferies analyst Kevin Grundy continues to recommend shares of Procter & Gamble as core Staples holding following "upbeat" meetings with management. Trian's involvement, while a distraction, has raised the execution bar, Grundy tells investors in a research note. The analyst notes that the company sees little merit in adding Trian to the board. Grundy believes P&G's structural and portfolio changes are "bearing fruit" and that shares offer multiple expansion potential from current levels. He keeps a Buy rating on the shares with a $103 price target.
09/14/17
MACQ
09/14/17
INITIATION
Target $102
MACQ
Outperform
Procter & Gamble initiated with an Outperform at Macquarie
Macquarie analyst Caroline Levy initiated Procter & Gamble with an Outperform and a $102 price target. Levy said there are early signs of improvements and expects activist Nelson Peltz to "prod" the company to move faster in shifting management control and responsibility to local markets and pay for performance.
09/19/17
JEFF
09/19/17
NO CHANGE
Target $104
JEFF
Buy
Jefferies sees Trian as 'win-win' for P&G shareholders
After meeting with Nelson Peltz and the Trian team, Jefferies analyst Kevin Grundy continues to recommend shares of Procter & Gamble. Trian's involvement raises the execution bar, setting up a "win-win" for shareholders, Grundy tells investors in a research note. He raised his price target for P&G shares to $104 from $103 and keeps a Buy rating on the name.
10/04/17
GSCO
10/04/17
DOWNGRADE
Target $87
GSCO
Neutral
Kraft Heinz downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Jason English downgraded Kraft Heinz (KHC) to Neutral and lowered his price target for the shares to $87 from $95. The analyst sees greater downside risk to estimates than upside with input cost pressure mounting. After updating his estimates across the Americas Consumer Staples group, English sees increasing risk to margin expectations as renewed input cost pressures challenge pricing power. He keeps Sell ratings on J.M. Smucker (SJM), General Mills (GIS), Church & Dwight (CHD) and Procter & Gamble (PG).

TODAY'S FREE FLY STORIES

WEN

Wendy's

$16.22

0.12 (0.75%)

09:47
02/22/18
02/22
09:47
02/22/18
09:47
Hot Stocks
Wendy's says testing expanded value menu »

Says raised menu prices…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 07

    Mar

  • 30

    May

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

, DTEGY

Deutsche Telekom

$16.20

-0.07 (-0.43%)

09:47
02/22/18
02/22
09:47
02/22/18
09:47
Hot Stocks
Deutsche Telekom buys 230K shares of T-Mobile common stock »

In a regulatory filing,…

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

DTEGY

Deutsche Telekom

$16.20

-0.07 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 05

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/22/18
02/22
09:45
02/22/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

09:45
02/22/18
02/22
09:45
02/22/18
09:45
Recommendations
Owens Corning analyst commentary  »

Owens Corning price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
U.S. leading indicators preview: »

U.S. leading indicators…

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
Breaking General news story  »

New York Federal Reserve…

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
Leading Indicators to be reported at 10:00 »

January Leading…

SNAP

Snap

09:43
02/22/18
02/22
09:43
02/22/18
09:43
Hot Stocks
Snap slips after Kylie Jenner critique »

Early weakness in shares…Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

09:43
02/22/18
02/22
09:43
02/22/18
09:43
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

PG

Procter & Gamble

09:42
02/22/18
02/22
09:42
02/22/18
09:42
Hot Stocks
Procter & Gamble: 'Progress will not come in a straight line' »

Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 07

    Mar

HST

Host Hotels

, AOBC

American Outdoor Brands

$10.06

-0.12 (-1.18%)

09:40
02/22/18
02/22
09:40
02/22/18
09:40
Options
Unusually active option classes on open February 22nd »

Unusual total active…

HST

Host Hotels

AOBC

American Outdoor Brands

$10.06

-0.12 (-1.18%)

NXPI

NXP Semiconductors

$125.60

0.04 (0.03%)

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

CHK

Chesapeake

P

Pandora

WMT

Walmart

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

LMFA

LM Funding

$1.51

0.08 (5.59%)

, LFIN

Longfin

$34.20

-2.03 (-5.60%)

09:38
02/22/18
02/22
09:38
02/22/18
09:38
Periodicals
LM Funding takeover rumors discussed in web report »

The "GrooveVC"…

LMFA

LM Funding

$1.51

0.08 (5.59%)

LFIN

Longfin

$34.20

-2.03 (-5.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

09:37
02/22/18
02/22
09:37
02/22/18
09:37
Recommendations
QTS Realty Trust analyst commentary  »

QTS Realty Trust price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 04

    Mar

  • 05

    Mar

  • 15

    Mar

  • 03

    Apr

FSLR

First Solar

09:36
02/22/18
02/22
09:36
02/22/18
09:36
Downgrade
First Solar rating change  »

First Solar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

AVGO

Broadcom

$248.62

-1 (-0.40%)

, QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

09:36
02/22/18
02/22
09:36
02/22/18
09:36
Recommendations
Broadcom, Qualcomm, Xilinx, Analog Devices, Maxim Integrated, Marvell, Microsemi analyst commentary  »

RBC finds takeover…

AVGO

Broadcom

$248.62

-1 (-0.40%)

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

XLNX

Xilinx

$68.46

-0.73 (-1.06%)

ADI

Analog Devices

MXIM

Maxim Integrated

$61.75

-0.37 (-0.60%)

MRVL

Marvell

$23.19

-0.01 (-0.04%)

MSCC

Microsemi

$60.94

-0.52 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 06

    Mar

  • 08

    Mar

  • 22

    Mar

IDGX

AltheaDx

09:35
02/22/18
02/22
09:35
02/22/18
09:35
Initiation
AltheaDx initiated  »

AltheaDx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

09:34
02/22/18
02/22
09:34
02/22/18
09:34
Earnings
Sprouts Farmers Market sees FY18 EPS $1.22-$1.28, consensus $1.23 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

09:33
02/22/18
02/22
09:33
02/22/18
09:33
Earnings
Sprouts Farmers Market reports Q4 EPS 29c, consensus 15c »

Reports Q4 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NNBR

NN, Inc.

$25.40

0.25 (0.99%)

09:32
02/22/18
02/22
09:32
02/22/18
09:32
Hot Stocks
NN, Inc. acquires Bridgemedica, terms not disclosed »

NN announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SHPG

Shire

$125.03

-1.64 (-1.29%)

09:31
02/22/18
02/22
09:31
02/22/18
09:31
Recommendations
Shire analyst commentary  »

Shire post results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

  • 25

    Mar

09:30
02/22/18
02/22
09:30
02/22/18
09:30
General news
U.S. equities are mildly firmer »

U.S. equities are mildly…

AYX

Alteryx

09:30
02/22/18
02/22
09:30
02/22/18
09:30
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
02/22/18
02/22
09:30
02/22/18
09:30
General news
Breaking General news story  »

Week of 2/18 Bloomberg…

WEX

Wex

09:28
02/22/18
02/22
09:28
02/22/18
09:28
Recommendations
Wex analyst commentary  »

Wex price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

APLS

Apellis

$14.77

0.13 (0.89%)

09:27
02/22/18
02/22
09:27
02/22/18
09:27
Hot Stocks
Apellis announces 18-month results of Phase 2 study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.